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Purpose/Objective: Management of intra-fractional tumor 
motion plays an emerging role in modern high-precision 
radiotherapy. Online localization of tumor positions is an 
essential prerequisite to enable steep dose falloffs close to 
the edges of the target volume. Approaches based on 2D 
images to directly track the target may suffer from varying 
tumor visibility. As a common remedy, the motion of 
anatomical surrogates correlating with the motion of the 
tumor is tracked instead to model the tumor positions. 
However, most approaches are restricted to merely assess 
the superior-inferior (SI) motion of the target, disregarding 
its left-right (LR) direction, which in turn needs to be 
compensated by increased margins.  
This shortcoming is addressed by a model-based approach 
that incorporates the motion of the diaphragm and the heart 
in order to account for both LR and SI tumor motion 
directions. 
Materials and Methods: Fluoroscopic image sets of two 
patients (187 images each) were analyzed retrospectively. 
The developed approach to localize the position of tumors 
located in the left lung is based on a) the motion assessment 
of surrogate structures and b) an appropriate model to 
extract the tumor localization according to the combined 
surrogate displacement. The breathing motion, mainly 
directed in SI, is incorporated by the use of the diaphragm as 
a surrogate. However, for the LR motion of lung tumors, the 
heart can be a substantial motion-inducing source. Pre-
segmented upper contours of the diaphragm and lateral 
contours of the heart are used to assess the motion of both 
surrogates (see Figure 1). In detail, the motion of a surrogate 
is represented by a fixed amount of 30 equally distributed 
corresponding points, between two different time steps. All 
of the corresponding points of both surrogates are used as an 
input for a thin-plate-spline interpolation in order to model 
the tumor motion. For reference, tumor positions in each 
frame for both patients were manually determined by four 
experts. The results were compared to the mean of those 
positions. 
 
Results: Using only the motion of the diaphragm as a 
surrogate for tumor motion, the resulting mean localization 
accuracy of the developed approach was 1.7 mm in LR and 
1.1 mm in SI direction. An improvement of the LR accuracy 
was achieved by additionally incorporating the heart motion. 
The combination of both surrogates resulted in an accuracy 
of 0.8 mm in LR and 1.0 mm in SI direction (see Table 1). The 
mean inter-observer variability accounts for 0.8 mm in LR 
and 1.3 mm in SI direction. 
 
 
 
Conclusions: With the presented approach, the breathing as 
well as the motion of the heart was taken into account in 
order to achieve accurate 2D tumor localization without 
relying on tumor visibility. The ability to tailor the approach 
to the patient- and situation-specific anatomy allows 
individual tumor motion modeling. 
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Purpose/Objective: This study aims to compare the 
performance of large breast cases treated with tomotherapy 
in supine and prone position during planning as well as 
treatment delivery status in terms of dosimetry and 
consistency.  
Materials and Methods: 40 patients who required whole 
breast irradiation were included. 10 patients were assgined 
to prone setup, while the rest were supine. CTV was defined 
as entire breast tissue and PTV was yielded by adding 3mm 
excluding the heart, lungs and air outside skin. Each patient 
received 25 fractions tomotherapy with 50Gy prescribed to 
CTV. Daily pretreatment MVCT was performed for setup 
verification, and daily delivered dose was estimated by 
recalculating the dose distribution on corresponding MVCT 
based on the treatment sinogram. All daily doses were then 
accumulated by deformable registration to give the actual 
delivered dose in the whole treatment course. Unpaired t-
test was used to compare both the planned dose (PD) and 
treated dose (TD) between supine and prone position. 
Results: All results are listed in Table 1. During planning, the 
target PDs achieved in prone position were slightly better. 
The mean D95% were 51.2±1.1Gy and 51.1±1.0Gy in CTV and 
50.3±1.0Gy and 49.5±1.2Gy in PTV for prone and supine cases 
respectively. Planned PTV D98% was significantly higher in 
prone setup (p=0.0299). Homogeneity index (HI) were ~0.15 
in PTV for both setups. During treatment, the target TDs 
were doing slightly better in supine cases instead, although 
they were all lower than their corresponding PDs in both 
positions. The mean treated D95% were 50.3±1.2Gy and 
50.2±2.4Gy in CTV and 48.2±1.4Gy and 48.0±2.2Gy in PTV for 
prone and supine cases respectively. HI was lower in supine 
(0.19) compared to prone case (0.24), indicating better 
target homogeneity in supine position. No significant results 
were found in target TDs.  
Lung dose could be decreased significantly (40%) in prone 
setup during planning. Mean V20Gy for ispilateral lung were 
9.3±4.8% and 15.7±3.1% in prone and supine cases 
respectively (p<0.0001). The PDs to contralateral lung and 
breast, heart and spinal cord were all lower in prone cases 
while the liver dose was lower for supine cases with no 
significant difference. Consistent results were found in all 
OARs when comparing the TDs between supine and prone 
cases. Mean treated V20Gy for ispilateral lung was 9.8±5.0% in 
prone cases compared to 16.2±3.6% in supine cases 
(p<0.0001). 
Conclusions: Considerable volume of ispilateral lung could be 
avoided when treated in prone position not only in planning 
stage but also in actual treatment. Although no significant 
results were found in targets, inconsistent result in planned 
and treated target dose comparison between supine and 
prone cases suggested the risk of larger setup variation in 
prone cases with highly mobile hanging breast could outweigh 
the dosimetric benefits in planning. Treated dose evaluation 
should be performed which also can account for daily setup 
discrepancies that may affect final treatment outcome. 
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Purpose/Objective: Abdominal compression has been 
commonly used as a method of limiting tumor motion during 
SBRT treatment of abdomen tumors. However, abdominal 
residual motion could occur during the beam on time. This 
study investigated the effectiveness of abdominal 
compression during SBRT of pancreas tumor using the new 
Calypso feature of using surface transponders. 
